Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study

Guoming Shi, Xiaoyong Huang, Xiaowu Li, Fei Liang, Qiang Gao, Daohan Zhang, Jia‐Cheng Lu, Yuan Ji, Zhiqiang Hu, Yi Chen, Shuang‐Jian Qiu, Yong Yi, Xiaodong Zhu, Hui‐Chuan Sun, Yinghong Shi, MinJie Peng, Xiaoying Wang, Cheng Huang, Zhen‐Bin Ding, Yifeng He, Ying-Hao Shen, Yongfeng Xu, Yong‐Sheng Xiao, Jie Hu, Jian Zhou, Jia Fan